Portfolio Company Headlines


September 15, 2014

Georgetown, TX
Molecular Templates Announces Completion of $12M Series C Financing

September 13, 2014

Washington, DC
Clean-Tavi trial shows Claret Medical cerebral protection system dramatically reduces brain lesions and neurological events following transcatheter aortic valve replacement (TAVR)

September 8, 2014

St. Louis, MO
EndoStim Files Registration Statement for Proposed Initial Public Offering of Common Stock

September 8, 2014

Georgetown, TX
Molecular Templates announces FDA approval of investigational new drug application for CD20 internalizing immunotoxin MT-3724

September 6, 2014

Santa Rosa, CA
Claret Medical® Raises up to $18 Million in Series B Financing to Advance the Field of Cerebral Protection

February 4, 2014

Austin, TX
Lumos Pharma Announces Series A Financing

November 19, 2013

Dallas, TX
ChanRx’s Phase 2b Study Of Vanoxerine Shows Strong Safety And Statistically Significant Efficacy Signals For Treatment Of Atrial Fibrillation

October 28, 2013

Goleta, CA
BAROnova® Selected to the Fierce 15

April 30, 2013

Cleveland, OH
Trinity Health Selects Explorys’ Big Data Analytics Platform to Support Clinical Integration and Quality Initiatives

April 22, 2013

Goleta, CA
BAROnova® Announces the Results of ENDObesity® I Clinical Trial

February 15, 2013

Goleta, CA
BAROnova® Secures $27.3M Investment To Fund Clinical Trial For Weight-loss Device

November 7, 2012

Austin, TX
LDR Receives Approvable Letter from U.S. Food and Drug Administration for Two-­Level Mobi-C® Cervical Disc

November 7, 2012

Cleveland, OH
Legacy Health Selects Explorys as its Healthcare Big Data Platform for Value-Based Care Initiatives

October 25, 2012

Austin, TX
Spinal Restoration, Inc. Closes $5 Million Equity and Debt Financing Round

August 20, 2012

St. Louis, MO
EndoStimTM LES Stimulation Therapy for Gastro-esophageal Reflux Disease (GERD) Receives CE Mark